1.Mo XD，Tang BL Zhang XH，et al. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia. Int J Cancer，2016，139：2106-2115.

2.Wang Y，Liu QF，Xu LP，et al. Haploidentical vs identical-sibling transplant for AML in remission：a multicenter，prospective study. Blood，2015，125：3956-3962.

3.Wang Y，Liu Q，Xu LP，et al. Haploidentical versus Matched-Sibling Transplant in Adults With Philadelphianegative high-risk Acute Lymphoblastic Leukemia：A biologically phase 3 randomized study. Clin Cancer Res，2016，22：3467-3476.

4.Wang Y，Wang HX，Lai YR，et al. Haploidentical transplant for myelodysplastic syndrome：registry-based comparison with identical sibling transplant. Leukemia，2016，30：2055-2063.

5.Sun Y，Beohou E，Labopin M，et al. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission：a retrospective pair-matched comparative study of the Beijing approach with the EBMT database. Haematologica，2016，101：e352-354.

6.Xu L，Chen H，Chen J，et al. The consensus on indications，conditioning regimen，and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol，2018，11：33.

7.Wang Y，Chang YJ，Xu LP，et al. Who is the best donor for a related HLA haplotype-mismatched transplant？Blood，2014，124：843-850.

8.Chang YJ，Luznik L，Fuchs EJ，et al. How do we choose the best donor for T-cell-replete，HLA-haploidentical transplantation？J Hematol Oncol，2016，9：35.

9.常英军.我如何选择异基因HSCT供者.中华血液学杂志，2016，37：643-649.

10.Wang Y，Wu DP，Liu QF，et al. Donor and recipient age，gender and ABO incompatibility regardless of donor source：validated criteria for donor selection for haematopoietic transplants. Leukemia，2018，32（2）：492-498.